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WomenAbstract Objective: Medication use during pregnancy is a major concern for most women. The
aim of the present study was to assess medication use, knowledge and beliefs about medications
among pregnant women in Saudi Arabia.
Methods: More than 760 pregnant women, attending the obstetric clinic, ﬁlled a semi-structured
questionnaire. Data were collected about their sociodemographic background, medication use dur-
ing pregnancy, medication/pregnancy risk awareness, sources of drug information and beliefs about
medications.
Results: Most women had a positive attitude toward medications in general but they believed
pregnant women should be more cautious regarding drug-use during pregnancy. A signiﬁcant asso-
ciation was found between participants’ education and occupation, and beliefs about medications.
In this context, well educated women and those working in a health-related career demonstrated
more correct beliefs about medications. Women with health-related occupations were more knowl-
edgeable about the life saving effect of drugs on unborn children. Women indicated inadequate pro-
vision of drug-related information from physician and pharmacist; they rely on medication
pamphlet to get such information. The most frequently used drugs were paracetamol and vitamins
(13.2%). Most pregnant women (59.2%) were able to identify drugs to-be avoided in pregnancy
that agreed roughly with FDA categories with 23 hits out of 32. They indicated that newborn anom-
alies (6.5%) were not attributed to drug-use during pregnancy.
Conclusion: During pregnancy, women were more conservative and skeptic toward medication,
health-care professionals should be aware of such attitudes when advising pregnant women to take
medication.
ª 2013 Production and hosting by Elsevier B.V. on behalf of King Saud University.1. Introduction
Pregnancy is a special physiological state where medication in-
take presents a challenge and a concern due to altered drug
pharmacokinetics and drug crossing the placenta possibly
causing harm to the foetus (Banhidy et al., 2005). Medication
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pregnant women may have chronic pathological conditions
that require continuous or interrupted treatment (e.g. asthma,
epilepsy, and hypertension). Also during pregnancy new med-
ical conditions can develop and old ones can worsen (e.g. mi-
graine, headache, hyperacidity, nausea and vomiting)
requiring drug therapy (Deborah et al., 2005). So it becomes
a major concern for pregnant women to take medication
whether prescription, over-the counter, or herbal medication.
Since the thalidomide era, there has been great awareness
about harmful effects of medications on the unborn child (Ka-
cew, 1994; Melton, 1995). It has been documented that con-
genital abnormalities caused by human teratogenic drugs
account for less than 1% of total congenital abnormalities
(Sachdeva et al., 2009). Hence in 1979, Food and Drug Admin-
istration developed a system that determines the teratogenic
risk of drugs by considering the quality of data from animal
and human studies (Sachdeva et al., 2009). FDA classiﬁes var-
ious drugs used in pregnancy into ﬁve categories, categories A,
B, C, D and X. Category A is considered the safest category
and category X is absolutely contraindicated in pregnancy
(FDA, 2005). This provides therapeutic guidance for the
clinician.
Beliefs about medication have been shown to strongly asso-
ciate with patients adherence to medication (Gatti et al., 2009).
The Beliefs about Medicines Questionnaire (BMQ) was devel-
oped in an attempt to express people’s perceptions about med-
icines (Horne et al., 1999). The BMQ-General scale has been
extensively used to assess opinions toward medicines among
people with no common condition or treatment (Horne and
Weinman, 1999; Mardby et al., 2009; Porteous et al., 2010).
Progressively, various BMQs-Speciﬁc have been developed
and used for each individual pathological condition. For
example, one BMQ was developed for patients with rheuma-
toid arthritis (Neame and Hammond, 2005), another one
was used to predict reﬁll adherence to inhaled corticosteroids
(Menckeberg et al., 2008) while a recent Swedish study used
a BMQ for assessing the impact of the beliefs about medicines
and personality traits on adherence to treatment with asthma
medications (Emilsson et al., 2011).
Few attempts were made to identify the sociodemographic
characteristics of pregnant women correlated with attitudes
and beliefs regarding medications (Nordeng et al., 2010a,b;
Rizk et al., 1993; Skouteris et al., 2008). Among these, educa-
tion, socioeconomic level, age, occupation, lifestyle, common
beliefs as well as severity of illness were reported. A patient’s
knowledge and capacity to get knowledge are important in
the development of beliefs (DiMatteo et al., 2007; Veazie
and Cai, 2007). Although some pregnant women may have
the sufﬁcient knowledge about high-risk medication in preg-
nancy, there is a ‘‘general fear’’ from medications (Nordeng
et al., 2010b). The hesitation in medication use by pregnant
women might result in serious consequences which include
but are not limited to: termination of a wanted pregnancy
(Einarson, 2007), reluctance to drug-use for nausea and vom-
iting (Baggley et al., 2004), preference of herbal medications
(Glover et al., 2003), non-compliance to prescriber’s medica-
tion (Ito et al., 1993; Williams et al., 2002) and inclination to-
ward OTC drugs (Erebara et al., 2008) and other self-
medication methods (Holst et al., 2009). Medication use in
pregnancy has been studied in different communities. Norwe-
gian women demonstrated a positive attitude toward medica-tion in general, but a more restrictive one during pregnancy
(Nordeng et al., 2010a). In Serbia, women had higher drug
exposure during (34.7%) than before pregnancy (29.9%)
(Odalovic et al., 2012) and less self-medication with over the
counter drugs. In Tanzania, most (66.5%) pregnant women re-
ported that they hesitated to take medications without consult-
ing their physicians, and few (31.5%) were aware of certain
drugs that are contraindicated during pregnancy (Kamuhabwa
and Jalal, 2011).
To the best of our knowledge, no attempts were made to
spot the characteristics of pregnant women in the Saudi Com-
munity that inﬂuence the medication intake. Such study is
highly warranted since patients are believed to make deliberate
decisions regarding their drug taking, based on their beliefs
about the illness and its treatment. The objective of this study
was to assess use, knowledge, risk-awareness and beliefs about
medications of pregnant women in Saudi Arabia and to inves-
tigate whether women’s beliefs during pregnancy were associ-
ated with socio-demographic properties and their personal
medication use during pregnancy.
2. Methodology
2.1. Study design and population
This was a cross-sectional study in which an anonymous self-
completed questionnaire was distributed to more than 760
pregnant women attending obstetric clinics in two tertiary hos-
pitals in Taif, KSA. The study was conducted during a 16-
week study period from December 2011 to April 2012.
Inclusion criterion was women who are currently pregnant.
A written informed consent was obtained before participation
in the study. The study conformed to the ethical principles of
the National Committee of Medical and Bioethics, King
Abdulaziz City for Science and Technology (KACST),
Riyadh, KSA.
2.2. Data collection
Data were collected by means of a semi-structured (Appendix
I) questionnaire composed of 22 + 16-item developed in Ara-
bic language. Midwives provided aid to illiterate women in
explaining and ﬁlling the questionnaire. The questionnaire
was modiﬁed from a previously validated survey (Horne
et al., 1999; Nordeng et al., 2010a). Pregnant women were
asked to answer 22 questions that assess their sociodemo-
graphic characteristics (Q1–7), awareness of risk (Q8–Q12),
current medication use (Q13–Q16) and sources of drug infor-
mation (Q17–Q22). Moreover, their beliefs and attitudes
regarding medication use in general (statements M1–M7)
and in pregnancy (statements S1–S9) were evaluated as de-
scribed by Horne et al. (1999) and by Nordeng et al.,
(2010a) to which they should indicate if they agree, disagree,
or are uncertain.
2.3. Data analysis
The BMQ statements were trichotomized (agree, disagree, or
uncertain). Chi-square test was used to test for differences in
proportions between answers given to each of the 16 state-
ments, the women’s sociodemographic background, and use
of medication during pregnancy. SPSS version 16.0.1 was used.
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3.1. Characteristics of the study population
During the 16 weeks of the survey, 760 pregnant women
completed the questionnaire. Participants were similar to the
population of pregnant women in Taif city in KSA with re-
spect to geographic area, age, parity, and maternal status,
but higher % of those who had completed university-level edu-
cation (Table 1). The percentage of women with a college or
university degree who answered the questionnaire was
67.1%, compared to 32.9% secondary and pre-secondary
education. There was also great % for unemployed women,
where 81.6% of the participants are housewives; while 9.2%
of the women were employed in a non-health-related sector,
7.9% were employed in the health-care sector and 1.3% were
students. Interestingly, most of the pregnant women
participating in the study (85%) were multiparous (with two
or more pregnancies) while primaparous women constitute
about 15%.Table 1 Socio-demographic characteristics (n= 760).
Characteristics Number of pregnant
women (%)
Age (years)
20–30 260 (34.2)
30–40 340 (44.7)
40–50 160 (21.1)
Nationality
Saudi 540 (71.1)
Egyptian 60 (7.9)
Sudanese 30 (3.9)
Jordanian 30 (3.9)
Syrian 50 (6.6)
Indian 10 (1.3)
Pakistanis 20 (2.6)
Others 20 (2.6)
Education
Illiterate 60 (7.9)
Primary 50 (6.6)
Secondary 140 (18.4)
University 500 (65.8)
Postgraduate 10 (1.3)
Occupation
House-wife 620 (81.6)
Student 10 (1.3)
Health-related career employee 60 (7.9)
Other employee 70 (9.2)
Residence
Rural 750
Urban 10
Parity
First-time pregnancy 120 (15.8)
1–3 previous children 220 (28.9)
More than 3 previous children 420 (55.3)
Previous abnormal children
Yes 50 (6.6)
No 710 (93.4)3.2. Medication use
About 40% of the pregnant women reported having used med-
ications (either herbal or chemical drugs) during pregnancy.
The most commonly used drugs were paracetamol (acetamino-
phen) and vitamins (13.2% each), antibiotics (2.6%), herbal
remedies (4.6%), and medications to treat nausea and vomit-
ing in pregnancy (2.6%), NSAIDs, antihistaminics and heart-
burn medications (1.3%). Interestingly 59.9% of the women
mentioned that they have chosen not to take medication dur-
ing pregnancy (see Table 2).
3.3. Beliefs about medications
Women’s opinions about medications are presented in Tables
3 and 4.
Generally, most women believed that physicians prescribe
too many medicines (M1; 57.9%); that they place too much
trust in drugs (M6; 67.1%) while about half (52.6%) believed
that by taking more time with patients; the doctor would pre-
scribe fewer medicines (M7). The majority (78.9%) of pregnant
women agreed that it would be better for the foetus if they
cease medications (S2) and (88.2%) supported the statement
about being more careful in using medications during preg-
nancy (S3). Most (75%) women believed a physician’s consent
should be obtained before using natural remedies during preg-
nancy (S9).
3.3.1. Factors related to medication-use attitudes and beliefs of
pregnant women
Among the different social and demographic properties, the
education level and type of employment were signiﬁcantly
associated with the pregnant women’s opinion about drugs
(Figs. 1–3).
Regarding education, Fig. 1 reveals that pregnant women
with a lower education level agreed more often than those with
a higher education level that medications did more harm than
good (M4) and were addictive (M2) and poisonous (M5).
From Fig. 2, it is obvious that non educated women and those
with a lower education were more skeptical toward drugs (S1)
and think that physicians prescribe too much (S6) although
they think that drugs may save their fetus in life-threatening
conditions (S4) than women with a higher education. Non-
educated pregnant women were more conﬁdent toward the
use of natural and/or herbal remedies during pregnancy (state-Table 2 Medication Use during pregnancy (n= 760).
Drug Number of pregnant women (%)
Paracetamol 100 (13.2)
Antacid 10 (1.3)
NSAIDs 10 (1.3)
Antibiotics 20 (2.6)
Antihistaminics 10 (1.3)
Drugs for nausea and vomiting 20 (2.6)
Vitamins 100 (13.2)
Herbs 35 (4.6)
No medication 455 (59.9)
NSAIDs non-steroidal anti-inﬂammatory drugs.
Table 3 Pregnant women’s beliefs about medications in general (n= 760).
Statement Agree n (%) Disagree n (%) Uncertain n (%)
M1 Doctors prescribe too many medicines 440 (57.9) 170 (22.4) 150 (19.7)
M2 Most medicines are addictives 200 (26.3) 440 (57.9) 120 (15.8)
M3 Natural remedies are safer than medicines 340 (44.7) 220 (28.9) 200 (26.3)
M4 Medicines do more harm than good 220 (28.9) 350 (46.1) 190 (25)
M5 All medicines are poisons 200 (26.3) 370 (48.7) 190 (25)
M6 Doctors place too much trust on medicines 510 (67.1) 120 (15.8) 130 (17.1)
M7 If doctor had more time with patients; he would prescribe fewer medicines 400 (52.6) 230 (30.3) 130 (17.1)
Table 4 Pregnant women’s beliefs about medication use during current pregnancy (n= 760).
Statement Agree n (%) Disagree n (%) Uncertain n (%)
S1 All medicines can be harmful to the fetus 450 (59.2) 170 (22.4) 140 (18.4)
S2 Even if I’m ill and if not pregnant would
have taken medicines, I believe it’s better
for the fetus that I refrain from using
medicines during pregnancy
600 (78.9) 80 (10.5) 80 (10.5)
S3 I have a higher threshold for using medicines when
I’m pregnant than when I’m not pregnant
670 (88.2) 50 (6.6) 40 (4.3)
S4 Thanks to treatment with medicines
during pregnancy lives of many unborn
children are saved each year
350 (46.1) 250 (32.9) 160 (21.1)
S5 It is better for the fetus that I use
medicines and get well than to have
untreated illness during pregnancy
340 (44.7) 240 (31.6) 180 (23.7)
S6 Doctors prescribe too many medicines to
pregnant women
150 (19.7) 470 (61.8) 140 (18.4)
S7 Natural remedies can generally be used by
pregnant women
160 (21.1) 450 (59.2) 150 (19.7)
S8 Pregnant women should preferable(y) use
natural remedies during pregnancy
190 (25) 370 (48.7) 200 (26.3)
S9 Pregnant women should not use natural
remedies without the advice of doctor
570 (75) 90 (11.8) 100 (13.2)
422 N.M. Zaki, A.A. Albarraqments S7, S8) and they believe that they need not consult their
doctor before taking natural remedies (S9).
For 12 of the 16 statements, there was a signiﬁcant correla-
tion between occupation and agreement to various statements
in BMQ (Fig. 3). Women in health-related occupations were in
general encouraging medication-use (M2–M7) and more skep-
tical about herbal remedies in general (M3) and during preg-
nancy (S9). They also agreed more often than other women
that an untreated illness could be more harmful during preg-
nancy than the medication itself (S5). Housewives and those
who do not work in health-related job believe that they need
not check with their doctor before taking natural remedies
(S9).
3.4. Medication-related information sources
As shown in Fig. 4, the primary information sources of drugs
during pregnancy were their gynecologist (58.1%) then general
practitioner (GP; 13%) and pharmacist (11%). The media,
family and friends as well as the internet collectively contribute
by 10% to expecting women’s information about drugs in re-
sponse to Q17.In response to Q21, pregnant women (65%) indicated that
the physicians either not provide them (15%) or sometimes
provide (50%) them with information about medication while
prescribing (Fig. 5) although all of them (99.8%) were meeting
regularly with their doctors (Q20). Surprisingly, the majority
of women >40% reported not receiving information from
the pharmacist during dispensing the prescribed drug (Q22).
The data revealed that there was scarcity of information about
drugs where 78% of women reported reading the medication
leaﬂet in normal state (Q18) and further higher percent
(86%) in pregnancy state (Q19).3.5. Awareness about risk
Regarding the awareness of participants during pregnancy, all
pregnant women––except one––indicated that the critical time
for the drug use during pregnancy is the ﬁrst trimester (Q11).
In response to Q8, few pregnant women (5.6%) mentioned
having a previous abnormal child. They mentioned that the
congenital abnormality was visual, mental or physical (in re-
sponse to Q9). Nevertheless, the majority of these women
Figure 1 Percentage of women agreeing to general statements about medications according to the women’s education. After Chi-square
test was applied, only statements where education level was signiﬁcantly associated with agreement are shown. Non-educated;
Pre-university = primary and secondary school; University = college or university degree.
Figure 2 Percentage of women agreeing to general statements about medications according to the women’s occupation. After
Chi-square test was applied, only statements where education level was signiﬁcantly associated with agreement are shown. Non-educated;
Pre-university = primary and secondary school; University = college or university degree.
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in pregnancy (Q10).
The Food and Drug Administration system developed in
1979 for the teratogenic risk of drugs provides therapeutic
guidance for the clinician (Sachdeva et al., 2009). According
to the system, category A is considered the safest during
pregnancy while Category X is absolutely contraindicatedduring pregnancy (FDA, 2005; Pangle, 2006). To assess wo-
men’s awareness about risk medication, the questionnaire
asked them to enumerate the main drugs that should be
avoided during pregnancy (Q12). About 60% of the partic-
ipants were able, individually, to name some medications to
be avoided during pregnancy. By comparing the drugs men-
tioned by the pregnant women with the FDA categories of
Figure 3 Percentage of women agreeing to various statements according to the women’s occupation. After Chi-square test was applied,
only statements where education level was signiﬁcantly associated with agreement are shown.
Figure 4 Information sources on medication during current
pregnancy (n= 760).
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revealed with 23 hits out of 32 (Table 5). These results
indicated that a relatively good awareness of about 60%
of pregnant women in Taif in Saudi Arabia. Obviously, this
awareness may be due to the high % of educated women
participating in the study.
4. Discussion
Availability and access to drug-related information as well as
beliefs of pregnant women about medications determine their
decision on drug administration during pregnancy. The
attitudes and beliefs regarding medication use have been
extensively reported using beliefs about medications question-
naire (BMQ) (Jonsdottir et al., 2009; Jorgensen et al., 2006;
Mardby et al., 2007; Menckeberg et al., 2008); however, to
our knowledge, this is the ﬁrst Saudi study to speciﬁcallydescribe pregnant women’s use, beliefs and awareness toward
medications.
The beliefs about medication decides patient’s compliance
or adherence to a certain medication (De las Cuevas et al.,
2011; Saks et al., 2012), while this is true for different patients
(Emilsson et al., 2011; Farmer et al., 2006), it is even more
exaggerated for pregnant women; in this context, whenever
faced with the decision on whether or not to use medication
during pregnancy, women will ponder on multi-factors about
the need of the medication against the concerns about possible
risks to the fetus.
The current Saudi study demonstrated that most women
generally believed that medications are not harmful, yet they
should be used cautiously in pregnancy. This is in agreement
with previous studies reporting that pregnant women are very
cautious and often unsure about medication use, and that they
often have concerns regarding the risks of drug use during
pregnancy (Einarson, 2007; Koren et al., 1989; Sanz et al.,
2001).
Our Saudi study indicated that the majority of partici-
pants did not believe drugs are responsible for congenital
abnormalities of their newborns. An early study reported
19% of pediatric inpatients – in King Khalid University Hos-
pital in Riyadh city of Saudi Arabia – had congenital or
genetically-determined disorders (Bahakim, 1993). A more re-
cent study by Alshehri (2005) reported a higher percent
(59.1%) of neonates with congenital abnormalities in Asir
Central Hospital during six years (1997–2002). Although
the percent of congenital anomalies seemed to be rising in
The Arabian Peninsula (Al-Odaib et al., 2003), our study
demonstrated that 5.6% was the prevalence of anomalies in
the population studied herein. Our study indicated that preg-
nant women did not believe that drugs are responsible for
their newborn anomalies. Instead, the anomalies can be
attributed to parental consanguinity and family history. This
was reported in previous studies like Alshehri study
(Alshehri, 2005) and several other publications (Al-Abdulka-
reem and Ballal, 1998; Al-Hussain and Al-Bunyan, 1997;
Figure 5 Sources of drug-related information as indicated by pregnant women (n= 760).
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ous marriages in Saudi Arabia are high (60%) and this has
provided a background in which these genetic diseases
abound (Al-Hussain and Al-Bunyan, 1997).
Interestingly, most women in this study were reluctant or
unsure about the use of herbal remedies during pregnancy this
was reﬂected by low percent of herbal users (4.6% only). This
reﬂects a more conservative attitude than that seen in other
surveys among British, Italian and Norwegian women in which
over 57.8%, 50% and 36% of the women indicated using herbs
during pregnancy (Holst et al., 2009; Lapi et al., 2008;
Nordeng and Havnen, 2004). However, our ﬁndings agree with
a recent Norwegian study (Nordeng et al., 2010a). The recent
focus on possible adverse effects of herbal remedies and the
large controversy between different studies on the risk factors
for natural remedy use in pregnancy could be an explanation
for such a restrictive attitude (Holst et al., 2009; Kebede
et al., 2009; Tiran, 2005).
As previously shown in other communities, sociodemo-
graphic factors, such as education and occupation, may have
a signiﬁcant impact on patients’ attitudes and beliefs toward
medications (Horne and Weinman, 1999; Mardby et al.,
2007; Phatak and Thomas, 2006). In our study, a higher level
of education and health-related job were the only sociodemo-
graphic factors associated with more positive beliefs about
medications.
Our study revealed inadequate drug-related information
received by pregnant women especially from pharmacist.
While this may contribute to more negative beliefs on medi-
cations yet the high prevalence of well educated women par-
ticipating in the current study (majority were housewives)
makes it easier for the women to internet-search and gain
knowledge about drug-use in pregnancy. When compared
with women in other occupations, women in a health-related
occupation had more knowledge about the risks of untreated
illness during pregnancy and believed that physicians shouldbe consulted regarding the use of herbal remedies. This pos-
sibly reﬂects a higher degree of medical knowledge and trust
in physicians among women who work in health-related
ﬁelds.
The scarcity of information on medication may contribute
to the false and/or negative beliefs on medications. The scar-
city of information about drugs was revealed by the high %
of women who reported reading the medication leaﬂet in nor-
mal state (Q18; 78%) and further higher percent in pregnancy
state (Q19; 86%). This might also reﬂect their hesitation and
skepticism regarding drug usage in pregnancy.
The impact of having a higher frequency of well-educated
women, despite most being housewives, was also evident in
superior participants’ percent (60%) to categorize drugs
(safe/to be avoided). Most of these drugs were in agreement
with the FDA categorization with 23 hits out of 32 (about
72%). The educational status of women in Saudi Arabia is
quite in agreement with participants in our study. According
to the World Bank report 2008, 95.9% of female youths
(age 15–24) and 79.4% of female adults (ages 15 and above)
are literate. According to the World Bank report, female
students in higher education in Saudi Arabia outnumber
those in Jordan, Lebanon, Tunisia and West Bank and
Gaza. The high occurrence of multiparous women (85%)
also contributes to such good knowledge of to-be-avoided
medications.
It is noteworthy that 82% of the women participating in
this study are housewives. This is in agreement with the World
Bank report stating that women comprise 60% of Saudi Ara-
bia’s college students but only 21% of its labor force, much
lower than in neighboring countries.
5. Limitations
A limitation of this survey was the prevalence of well-edu-
cated women (67% reported a university degree) which
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pants’ awareness of medications or at least capability to
get knowledge about drugs. However this agrees with the
educational status of women in Saudi Arabia so it represents
the actual situation. Moreover, the study included a high
number of multiparous women (characteristic of the Saudi
community) who gained knowledge about drug use from
multi-pregnancy. These two issues may affect the transfer-
ability of our ﬁndings on the whole population. The re-
sponse rate was quite high where 92% of approached
women completed the survey.6. Conclusion
The study was indicative of the inﬂuence of the characteris-
tics of pregnant women in the Saudi Community on the med-
ication intake. The insufﬁcient information regarding drugs
in pregnancy from the clinical practitioners, is an area that
needs further improvement in the future. Pharmacists, with
expertise in providing women with positive beliefs about
medications during pregnancy and in optimizing drug ther-
apy outcomes, are valuable components of the healthcare
team and should be increasingly involved in public health ef-
forts. Health-care professionals should be aware of women’s
attitudes when advising them to take medication during
pregnancy.Ethical approval
The study did not require a review board approval. It is anon-
ymous and involves no risk to participants. Pregnant women
ﬁlled a questionnaire about their beliefs regarding medication
use in pregnancy. The research is non-controversial. There is
a consent statement in the questionnaire (see supporting infor-
mation ﬁle). The study conformed to the ethical principles of
the National Committee of Medical & Bioethics, King Abdu-
laziz City for Science and Technology (KACST), Riyadh,
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support during the execution of the study.Appendix I. Pregnant Women’s use, perception and knowledge
of medication, Saudi Study
Consent Statement: This survey is conducted to identify preg-
nant women’s perception of medicine use. The collected infor-
mation will be anonymously recorded (no need to write your
name) and only used for research purposes. As we go through
the questionnaire, please feel free not to answer if you do not
Table 5 Agreement between drugs to be avoided in pregnancy
(as indicated by participants) as compared to FDA
categorization.
Drugs FDA
categorization
Pregnant women
categorization
(drugs-to-be-avoided)
according to question 18
Analgesics and
antipyretics
B and C
p
Acetaminophen B ·
Aspirin C
p
Antiemetics: doxylamine,
meclizine, cyclizine,
dimenhydrinate
B NA
Antibiotics
Penicillin, Ampicillin,
Amoxycillin
B, C and D
p
Cloxacillin
Cephalosporins
B
p
Erythromycin B
p
Gentamicin C
p
Amikacin C/D
p
Streptomycin D
p
Sulfonamides B/D
p
Tetracyclines D
p
Amoebicides:
Metronidazole
B NA
Anthelmentics B NA
Anthelmentics:piperazine,
mebendazole
B NA
Antimalarials C NA
Antifungals C NA
Vitamins: B,C,D,E, folic
acid
A
p
Hormones
Thyroxine A
p
Androgens X Na
Estrogens X
p
Progestogens
Hydroxyprogestrone
D
Medroxyprogestrone D
p
Norethindrone X
p
Norgestrel X
p
Bronchodilators C NA
Others
Warfarin X
p
Vitamin A X
p
Oral Antidiabetics X
p
Anti-depressants X
p
Anticancer drugs X
p
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